IFPMA Notes for Guidance
- Note for Guidance on AI ethics principles
- Note for Guidance on social media and digital channels
- Note for Guidance on data ethics principles
- Joint Note for Guidance on telemedicine
- Note for Guidance on ethical third party intermediary relationships
- Note for Guidance on interactions with patients
- Note for Guidance on fees for services
- Note for Guidance on sponsorship of events and meetings
- Note for Guidance on medical education
- Note for Guidance on virtual and hybrid international medical congresses
The Ethos of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is centered on trust to “act with integrity and honesty to improve patient care and build trust with those we serve and to respect the independence of healthcare providers, patients, and other stakeholders.”
The purpose of the various IFPMA “Notes for Guidance” is to provide additional interpretation and further guidance in relation to the relevant provisions of the Code of Practice. Notes for Guidance are non-binding and must be read with the spirit of the Code in mind and always in accordance with applicable laws and regulations and other applicable industry codes.
IFPMA member companies and member associations and anyone acting on their behalf are encouraged to consider the guidance given in Notes for Guidance when implementing the IFPMA Code of Practice in their daily practice.
The intention of Notes for Guidance is for the cooperation between companies, HCPs, and other stakeholders to always be based on high ethical standards and to clearly aim to benefit patients.